Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
Protein Networks02:26

Protein Networks

4.4K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A quantitative approach for defining the degradability landscape of protein degraders.

Nature communications·2026
Same author

Applying Artificial Intelligence and machine learning in precision nutrition.

Nature communications·2026
Same author

Lipid metabolism of hepatocyte-like cells supports intestinal tumor growth in Drosophila.

Nature communications·2026
Same author

A dietary switch promotes sensory neuron-dependent cancer-associated cachexia.

Science (New York, N.Y.)·2026
Same author

AI systems devise hypotheses and ways to test them.

Nature·2026
Same author

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026

Related Experiment Video

Updated: Dec 12, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K

A machine learning and network framework to discover new indications for small molecules.

Coryandar Gilvary1,2,3,4, Jamal Elkhader1,2,3,4, Neel Madhukar5

  • 1HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Dept. of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, United States of America.

Plos Computational Biology
|August 9, 2020
PubMed
Summary

A new computational method, CATNIP, identifies novel drug uses by analyzing molecular data, not just existing approvals. This approach accelerates drug repurposing and offers potential new treatments for diseases like Parkinson's and Type 2 Diabetes.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.8K

Related Experiment Videos

Last Updated: Dec 12, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.8K

Area of Science:

  • Computational drug discovery
  • Pharmacology
  • Bioinformatics

Background:

  • Traditional drug repurposing relies on anecdotal evidence or costly experimental screens.
  • Existing computational methods are limited to approved drugs, excluding investigational molecules.
  • A novel approach is needed to expand drug repurposing capabilities.

Purpose of the Study:

  • To present CATNIP, a computational drug repurposing approach.
  • To enable drug repurposing using only a molecule's biological and chemical information.
  • To identify broad-scale repurposing opportunities and specific drug candidates.

Main Methods:

  • Trained CATNIP on 2,576 small molecules using 16 similarity features (structural, target, pathway).
  • Developed a repurposing network to identify drug class and specific molecule opportunities.
  • Validated predictions with literature evidence and identified potential therapeutic uses.

Main Results:

  • CATNIP achieved significant predictive power with an AUC of 0.841.
  • Identified systemic hormonal preparations for respiratory illnesses.
  • Predicted adrenergic uptake inhibitors (amitriptyline, trimipramine) for Parkinson's disease.
  • Predicted the kinase inhibitor vandetanib for Type 2 Diabetes.

Conclusions:

  • CATNIP offers a systematic and efficient computational approach to drug repurposing.
  • The method expands drug repurposing to investigational molecules.
  • This work streamlines future drug development and identifies novel therapeutic strategies.